Page last updated: 2024-10-27

fluspirilene and Atherosclerotic Parkinsonism

fluspirilene has been researched along with Atherosclerotic Parkinsonism in 3 studies

Fluspirilene: A long-acting injectable antipsychotic agent used for chronic schizophrenia.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frangos, H1
Zissis, NP1
Leontopoulos, I1
Diamantas, N1
Tsitouridis, S1
Gavriil, I1
Tsolis, K1
Tegeler, J1
Lehmann, E1
Weiher, A1
Heinrich, K1
Bulens, C1
Meerwaldt, JD1
van der Wildt, GJ1
Keemink, CJ1

Trials

1 trial available for fluspirilene and Atherosclerotic Parkinsonism

ArticleYear
Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics.
    Acta psychiatrica Scandinavica, 1978, Volume: 57, Issue:5

    Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Fluphenazine; Fluspir

1978

Other Studies

2 other studies available for fluspirilene and Atherosclerotic Parkinsonism

ArticleYear
Safety of long-term neuroleptanxiolysis with fluspirilene 1.5 mg per week.
    Pharmacopsychiatry, 1990, Volume: 23, Issue:6

    Topics: Akathisia, Drug-Induced; Anxiety Disorders; Benzodiazepines; Drug Administration Schedule; Drug Ther

1990
Visual contrast sensitivity in drug-induced Parkinsonism.
    Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:3

    Topics: Adolescent; Adult; Bipolar Disorder; Depressive Disorder; Drug Therapy, Combination; Female; Fluspir

1989